These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 11373000)

  • 1. The detection of psilocin in human urine.
    Grieshaber AF; Moore KA; Levine B
    J Forensic Sci; 2001 May; 46(3):627-30. PubMed ID: 11373000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of psilocin in body fluids.
    Sticht G; Käferstein H
    Forensic Sci Int; 2000 Sep; 113(1-3):403-7. PubMed ID: 10978655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples.
    Kamata T; Nishikawa M; Katagi M; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):421-7. PubMed ID: 14581081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psilocin identified in a DUID investigation.
    Tiscione NB; Miller MI
    J Anal Toxicol; 2006 Jun; 30(5):342-5. PubMed ID: 16839473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, hydrolysis and stability of psilocin glucuronide.
    Martin R; Schürenkamp J; Pfeiffer H; Lehr M; Köhler H
    Forensic Sci Int; 2014 Apr; 237():1-6. PubMed ID: 24513688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of psilocybin and psilocin in Psilocybe subcubensis Guzmán by ion mobility spectrometry and gas chromatography-mass spectrometry.
    Keller T; Schneider A; Regenscheit P; Dirnhofer R; Rücker T; Jaspers J; Kisser W
    Forensic Sci Int; 1999 Jan; 99(2):93-105. PubMed ID: 10077856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a psilocin immunoassay for serum and blood samples.
    Albers C; Köhler H; Lehr M; Brinkmann B; Beike J
    Int J Legal Med; 2004 Dec; 118(6):326-31. PubMed ID: 15526212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin's main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma.
    Kolaczynska KE; Liechti ME; Duthaler U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122486. PubMed ID: 33485158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples.
    Kamata T; Nishikawa M; Katagi M; Tsuchihashi H
    J Forensic Sci; 2005 Mar; 50(2):336-40. PubMed ID: 15813544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levels of psilocybin and psilocin in various types of mushrooms].
    Stríbrný J; Borovicka J; Sokol M
    Soud Lek; 2003 Jul; 48(3):45-9. PubMed ID: 14631713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of psilocin in rat urine by high-performance liquid chromatography with electrochemical detection.
    Kysilka R
    J Chromatogr; 1990 Dec; 534():287-90. PubMed ID: 2094720
    [No Abstract]   [Full Text] [Related]  

  • 12. A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability.
    Martin R; Schürenkamp J; Pfeiffer H; Köhler H
    Int J Legal Med; 2012 Nov; 126(6):845-9. PubMed ID: 22138681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.
    Hasler F; Bourquin D; Brenneisen R; Bär T; Vollenweider FX
    Pharm Acta Helv; 1997 Jun; 72(3):175-84. PubMed ID: 9204776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.
    Brown RT; Nicholas CR; Cozzi NV; Gassman MC; Cooper KM; Muller D; Thomas CD; Hetzel SJ; Henriquez KM; Ribaudo AS; Hutson PR
    Clin Pharmacokinet; 2017 Dec; 56(12):1543-1554. PubMed ID: 28353056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man.
    Hasler F; Bourquin D; Brenneisen R; Vollenweider FX
    J Pharm Biomed Anal; 2002 Sep; 30(2):331-9. PubMed ID: 12191719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction.
    Lindenblatt H; Krämer E; Holzmann-Erens P; Gouzoulis-Mayfrank E; Kovar KA
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(2):255-63. PubMed ID: 9657222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An aqueous-organic extraction method for the isolation and identification of psilocin from hallucinogenic mushrooms.
    Casale JF
    J Forensic Sci; 1985 Jan; 30(1):247-50. PubMed ID: 4038992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.
    Martin R; Schürenkamp J; Gasse A; Pfeiffer H; Köhler H
    Int J Legal Med; 2013 May; 127(3):593-601. PubMed ID: 23183899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.
    Dinis-Oliveira RJ
    Drug Metab Rev; 2017 Feb; 49(1):84-91. PubMed ID: 28074670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of ketamine and norketamine in urine by automatic solid-phase extraction (SPE) and positive ion chemical ionization-gas chromatography-mass spectrometry (PCI-GC-MS).
    Kim EM; Lee JS; Choi SK; Lim MA; Chung HS
    Forensic Sci Int; 2008 Jan; 174(2-3):197-202. PubMed ID: 17553643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.